Table 1.
Altered gut microbial compositions associated with CVDs in human and animal studies
| Species | Disease | Sample size | Technique | Altered gut microbial abundance |
References | |
|---|---|---|---|---|---|---|
| Increase | Decrease | |||||
| Human | Symptomatic atherosclerosis | 12 symptomatic atherosclerotic plaques, 13 controls | Metagenomic sequencing | Collinsella | Roseburia and Eubacterium | Karlsson et al.13 |
| Human | Atherosclerotic cardiovascular disease | 218 atherosclerotic cardiovascular disease (ACVD), 187 controls | Metagenomic sequencing | Streptococcus and Escherichia | Bacteroides and Prevotella | Jie et al.18 |
| Human | Coronary artery disease | 15 CAD, 5 controls | 16S sequencing | Prevotella | Clostridium and Faecalibacterium | Gózd-Barszczewska et al.39 |
| Human | Hypertension | 56 pre-hypertension, 99 primary hypertension, 41 controls | Metagenomic sequencing | Prevotella and Klebsiella | Li et al.15 | |
| Human | Hypertension | 60 primary hypertension, 60 controls | Metagenomic sequencing | Klebsiella spp., Streptococcus spp., and Parabacteroides merdae | Roseburia spp. and Faecalibacterium prausnitzii | Yan et al.35 |
| Human | Heart failure | 20 HF, 20 controls | 16S sequencing | Blautia, Collinsella, uncl. Erysipelotrichaceae and uncl. Ruminococcaceae | Luedde et al.40 | |
| Human | Chronic heart failure | 60 mild CHF, 30 moderate to severe CHF, 20 controls | Incubation using a selective agar | Campylobacter, Shigella, Salmonella, Yersinia enterocolitica, and Candida species | Luedde et al.40 | |
| Human | Chronic heart failure | 53 CHF, 41 controls | Metagenomic sequencing | Ruminococcus gnavus | Faecalibacterium prausnitzii | Cui et al.36 |
| Human | Atrial fibrillation | 50 atrial fibrillation, 50 controls | Metagenomic sequencing | Ruminococcus, Streptococcus, and Enterococcus | Faecalibacterium, Alistipes, Oscillibacter, and Bilophila | Zuo et al.41 |
| Human | Chronic Heart Failure | 22 CHF, 22 controls | Multicolor FISH analysis | Bacteroides/Prevotella, Eubacterium rectale, Fusobacterium prausnitzii (Fprau) | Sandek et al.42 | |
| Human | Heart failure | 84 HFrEF (40 discovery, and 44 validation), 266 controls | 16S sequencing | Uncultured bacterium, Prevotella, Hungatella, and Succiniclasticum | Lachnospiraceae family, Faecalibacterium and Bifidobacterium | Kummen et al.43 |
| Human | Cardiovascular disease | 76 type 2 diabetes and risk factors for CVDs | 16S sequencing | Roseburia, Eubacterium, and Faecalibacterium | Escherichia, Shigella, Bilophila, and Hungatella | Deng et al.44 |
| Human | Heart failure with preserved ejection fraction | 26 HFpEF, 67 controls | 16S sequencing | Firmicutes/Bacteroidetes | bacteria producing-SCFAs, particularly Ruminococcus | Beale et al.45 |
| Human | Hypertension | 6953 | Metagenomic sequencing | Firmicutes phylum change | Palmu et al.46 | |
| Human | Hypertension | 183 hypertension, 346 controls | 16S sequencing | Catabacter, Veillonella, Clostridium, Oscillibacter, Robinsoniella | Akkermansia, Ruminococcus, Anaerovorax, Sporobacter, Asaccharobacter | Palmu et al.47 |
| Human | Atherosclerosis | 226 atherosclerosis, 184 controls | Metagenomic sequencing | Streptococcus spp., Lactobacillus salivarius, Solobacterium moorei, and Atopobium parvulum | Bacteroides xylanisolvens, Odoribacter splanchnicus, Eubacterium eligens, Roseburia inulinivorans, and Roseburia intestinalis | Liu et al.34 |
| Human | Coronary artery disease | 70 coronary artery disease, 98 controls | 16S sequencing | Escherichia-Shigella and Enterococcus | Faecalibacterium, Subdoligranulum, Roseburia, and Eubacterium rectale | Zhu et al.37 |
| Human | Non-ischemic heart failure with reduced ejection fraction | 28 non-ischemic HFrEF, 19 controls | 16S sequencing | Streptococcus and Veillonella | SMB53 | Katsimichas et al.48 |
| Human | Heart failure | 12 HF, 12 controls | 16S sequencing | Eubacterium rectale and Dorea longicatena | Kamo et al.49 | |
| Human | Heart failure | 12 HF < 60 years, 10 HF > 60 years | 16S sequencing | Proteobacteria, Lactobacillus | Bacteroidetes, Faecalibacterium | Kamo et al.49 |
| Rabbits | Metabolic syndrome | 12 high-fructose high-fat diet (HFFD)-induced MetS, 9 controls | 16S sequencing | Firmicutes/Bacteroidetes ratio | Moughaizel et al.50 | |
| Rats | Hypertensive heart failure | 8 hypertensive heart failure (HHF) dahl salt-sensitive rat model, 8 controls | 16S sequencing | Firmicutes/Bacteroidetes | Muribaculaceae, Lachnospiraceae, and Lactobacillaceae | Li et al.51 |
| Rats | Hypertension | 7-8 per group SD rat | 16S sequencing | Verrucomicrobia phyla, Akkermansia genus | Hsu et al.52 | |
| Rats | Hypertension | 10 HSD, 10 controls | 16S sequencing | Erwinia genus, Christensenellaceae and Corynebacteriaceae families | Anaerostipes genus | Bier et al.53 |
| Mice | Atherosclerosis | 342 transgenes atherosclerotic mice | 16S sequencing | Roseburia sp. | Kasahara et al.54 | |
| Mice | Heart failure | 14 Thoracic aortic constriction (TAC) surgery, 8 controls | 16S sequencing | Helicobacter, Rikenellaceae, Colidextribacter, and Lactobacillus | Prevotellaceae, Muribaculum, and Rikenella | Bao et al.55 |
| Mice | Atherosclerosis | pro-atherogenic LDLr −/− ApoB100/100 mice either a low-fat/high-sucrose (LFHS) or a high-fat/low-sucrose (HFLS) diet | 16S sequencing | Lachnospiraceae, Rumino_Ruminococcus, Ruminococcaceae, Dorea, Oscillospira, Clostridiales, Coprococcus in LFHS-fed mice | Perazza et al.56 | |